cabazitaxel fresenius kabi
fresenius kabi polska sp.z.o.o. - kabazitakselis - koncentratas infuziniam tirpalui - 20 mg/ml - cabazitaxel
cabazitaxel teva
teva b.v. - kabazitakselis - koncentratas infuziniam tirpalui - 10 mg/ml - cabazitaxel
tifay
stada arzneimittel ag - teriflunomidas - plėvele dengtos tabletės - 14 mg - teriflunomide
bozilos
egis pharmaceuticals plc - teriflunomidas - plėvele dengtos tabletės - 14 mg - teriflunomide
tibsovo
les laboratoires servier - ivosidenib - leukemia, myeloid, acute; cholangiocarcinoma - antinavikiniai vaistai - tibsovo in combination with azacitidine is indicated for the treatment of adult patients with newly diagnosed acute myeloid leukaemia (aml) with an isocitrate dehydrogenase-1 (idh1) r132 mutation who are not eligible to receive standard induction chemotherapy (see section 5. tibsovo monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic cholangiocarcinoma with an idh1 r132 mutation who were previously treated by at least one prior line of systemic therapy.
meliterix
norameda, uab - teriflunomidas - plėvele dengtos tabletės - 14 mg - teriflunomide
cabazitaxel stada
stada arzneimittel ag - kabazitakselis - koncentratas infuziniam tirpalui - 20 mg/ml - cabazitaxel
lipanthyl
lex ano, uab - fenofibratas - kietosios kapsulės - 200 mg - fenofibrate
lipanthyl 200m
niromed, uab - fenofibratas - kietosios kapsulės - 200 mg - fenofibrate